Precision Oncology Symposium EXHIBIT OPPORTUNITY

EXHIBIT OPPORTUNITY:

ANCO & MOASC Present: Precision Oncology Symposium 2026 

InterContinental San Francisco, November 7, 2026

Event Details:

Date: November 7, 2026

Location: InterContinental San Francisco, 888 Howard Street, San Francisco, CA 94103

Support for this meeting is being sought at two levels from our ANCO 2026 Corporate Members:

• Major Supporter: provides 2 exhibitor badges, 2 industry meeting registrations, priority acknowledgment, and exhibit space for a fee of $8,500 for members and $10,500 for non-members.
• Supporter: provides 2 exhibitor badges and exhibit space for a fee of $4,200 for members and $5,250 for non-members.

Please note: persons with an exhibitor badge may attend the conference sessions space permitting.

Please click the links below to access the necessary documents:

Draft Event Agenda

ANCO’s 2026 W-9

How to Secure Your Space:

Exhibit space is space on a first come, first served basis. Our exhibitor agreement is now online; please follow the steps below to reserve your spot:

• To Complete the Exhibitor Agreement: Click HERE, select the orange Register button (top right), enter your email, and click Next to submit your form.

• Note: If you need any internal documents, agreements, or forms signed on our end to get your funding approved, please email them to ashley@anco.org and we will gladly sign them to expedite the process.

• Submit Payment: To fully finalize your reservation, please ensure payment for your exhibit space is completed by October 19, 2026

Payment Terms: All exhibitor payments must be received in full by October 19, 2026.

• Cancellations prior to October 19, 2026:  written cancellation requests received before October 19, 2026, will be refunded, minus a 10% administrative fee.

• Cancellations on or after October 19, 2026: no refunds will be issued for cancellations received on or after October 19, 2026

• Unpaid agreements: canceling an exhibitor agreement prior to ANCO receiving payment does not release the exhibitor from liability for outstanding funds due based on this policy.